Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionTwo Sigma Advisers, Lp
Latest Disclosed Ownership14,700 shares
Latest Disclosed Value $ 314,433
Two Sigma Advisers, Lp reports 15.52% decrease in ownership of PDC / Pediatrix Medical Group, Inc.

On February 17, 2026 - Two Sigma Advisers, Lp filed a 13F-HR form disclosing ownership of 14,700 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $270,480 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 17,400 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of -15.52% during the quarter. The current value of the position is $274,890 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 14,700 -2,700 -15.52 314 7.90 0.0006
2025-11-14 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 17,400 -2,100 -10.77 291 4.30 0.0006
2025-08-14 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 19,500 2,800 16.77 280 15.77 0.0006
2025-05-15 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 16,700 -300 -1.76 242 8.07 0.0005
2025-02-14 2024-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 17,000 -40,600 -70.49 223 -66.57 0.0005
2024-11-14 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 57,600 -89,800 -60.92 668 -40.02 0.0016
2024-08-14 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 147,400 -6,400 -4.16 1,113 -27.89 0.0025
2024-05-15 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 153,800 -43,400 -22.01 1,543 -15.88 0.0036
2024-02-14 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 197,200 13,500 7.35 1,834 -21.47 0.0043
2023-11-14 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 183,700 122,600 200.65 2,335 168.89 0.0060
2023-08-14 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 61,100 37,800 162.23 868 150.14 0.0022
2023-05-15 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 23,300 23,300 347 0.0009
2022-08-15 2022-06-30 13F MEDNAX COM 58502B106 0 -52,500 -100.00 0 -100.00
2022-05-16 2022-03-31 13F MEDNAX COM 58502B106 52,500 -12,400 -19.11 1,233 -30.18 0.0033
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 64,900 -68,400 -51.31 1,766 -53.40 0.0044
2021-11-15 2021-09-30 13F MEDNAX COM 58502B106 133,300 -65,700 -33.02 3,790 -36.83 0.0098
2021-08-16 2021-06-30 13F MEDNAX COM 58502B106 199,000 -169,000 -45.92 6,000 -35.99 0.0158
2021-05-17 2021-03-31 13F MEDNAX COM 58502B106 368,000 -1,300 -0.35 9,373 3.42 0.0258
2021-02-16 2020-12-31 13F MEDNAX COM 58502B106 369,300 54,300 17.24 9,063 76.74 0.0242
2020-11-16 2020-09-30 13F MEDNAX COM 58502B106 315,000 38,400 13.88 5,128 8.41 0.0146
2020-09-15 2020-06-30 13F/A-1 MEDNAX COM 58502B106 276,600 -700 -0.25 4,730 46.53 0.0139
2020-08-14 2020-06-30 13F MEDNAX COM 58502B106 276,600 -700 4,730 13,668.1291
2020-05-15 2020-03-31 13F MEDNAX COM 58502B106 277,300 181,000 187.95 3,228 20.63 0.0124
2020-02-14 2019-12-31 13F MEDNAX COM 58502B106 96,300 96,300 2,676 0.0062
2019-11-14 2019-09-30 13F MEDNAX COM 58502B106 0 -70,700 -100.00 0 -100.00
2019-08-14 2019-06-30 13F MEDNAX COM 58502B106 70,700 70,700 1,784 0.0044
2018-05-15 2018-03-31 13F MEDNAX COM 58502B106 0 -11,084 -100.00 0 -100.00
2018-02-14 2017-12-31 13F MEDNAX COM 58502B106 11,084 -13,638 -55.17 592 -44.47 0.0016
2017-11-14 2017-09-30 13F MEDNAX COM 58502B106 24,722 24,722 1,066 0.0030
2016-05-16 2016-03-31 13F MEDNAX COM 58502B106 0 0 0 0.0000
2015-05-15 2015-03-31 13F MEDNAX COM 58502B106 0 -6,060 -100.00 0 -100.00
2016-02-09 2014-12-31 13F/A-1 MEDNAX COM 58502B106 6,060 6,060 0.00 401 0.00 0.0032
2015-02-17 2014-12-31 13F MEDNAX COM 58502B106 6,060 401
2014-08-14 2014-06-30 13F Mednax Common Stock 58502B106 0 -23,960 -100.00 0 -100.00
2014-05-15 2014-03-31 13F Mednax Common Stock 58502B106 23,960 19,300 414.16 1,485 498.79 0.0135
2014-02-14 2013-12-31 13F MEDNAX COM 58502B106 4,660 4,660 -30.76 248 -59.74 0.0024
2013-11-14 2013-09-30 13F MEDNAX COM 58502B106 0 -6,730 -100.00 0 -100.00
2013-08-14 2013-06-30 13F MEDNAX COM 58502B106 6,730 6,730 616 0.0088
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.